Sertraline Hydrochloride Tablet, Film Coated
Product Images NDC 55154-3569

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sertraline Hydrochloride (NDC 55154-3569). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (78d3579a 260f 4bb2 95f2 8ee8a60fae18 01)

Chemical structure of Sertraline Hydrochloride, showing the molecular arrangement including chlorine atoms and a methylammonium hydrochloride group.*

FDA Label Image

Bag Label (Fd8a815e 88b7 4bef 9e32 6dbc735711a3 00)

Label for Sertraline Hydrochloride tablets USP 100 mg, film-coated oral tablets. Package contains 10 tablets. The label includes storage instructions at 20° to 25°C, usage warning, and distribution details listing Cardinal Health and Major Pharmaceuticals. Manufactured by Lupin Limited, India.*

FDA Label Image

Bag Label (Fd8a815e 88b7 4bef 9e32 6dbc735711a3 01)

Label for Sertraline Hydrochloride tablets USP 50 mg, unit dose package containing 10 film-coated tablets. The label includes storage instructions, manufacturer Lupin Limited in India, and distributors Major Pharmaceuticals Inc. and Cardinal Health in the USA. It notes that the package is intended for institutional use only and is not child resistant.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.